HYUNDAI BIOLAND Co.Ltd (KQ:052260) — Market Cap & Net Worth
Market Cap & Net Worth: HYUNDAI BIOLAND Co.Ltd (052260)
HYUNDAI BIOLAND Co.Ltd (KQ:052260) has a market capitalization of $32.83 Million (₩48.45 Billion) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23383 globally and #1547 in its home market, demonstrating a -3.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HYUNDAI BIOLAND Co.Ltd's stock price ₩3230.00 by its total outstanding shares 15000000 (15.00 Million). See HYUNDAI BIOLAND Co.Ltd (052260) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
HYUNDAI BIOLAND Co.Ltd Market Cap History: 2015 to 2026
HYUNDAI BIOLAND Co.Ltd's market capitalization history from 2015 to 2026. Data shows change from $129.15 Million to $32.83 Million (-10.54% CAGR).
Index Memberships
HYUNDAI BIOLAND Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.02% | #762 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.02% | #762 of 1384 |
Weight: HYUNDAI BIOLAND Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HYUNDAI BIOLAND Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HYUNDAI BIOLAND Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
HYUNDAI BIOLAND Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
HYUNDAI BIOLAND Co.Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $129.15 Million | $80.90 Billion | $10.79 Billion | 0.00x | 0.01x |
| 2016 | $85.01 Million | $97.81 Billion | $12.43 Billion | 0.00x | 0.01x |
| 2017 | $96.44 Million | $102.56 Billion | $11.98 Billion | 0.00x | 0.01x |
| 2018 | $77.59 Million | $100.59 Billion | $15.05 Billion | 0.00x | 0.01x |
| 2019 | $104.82 Million | $106.31 Billion | $10.85 Billion | 0.00x | 0.01x |
| 2020 | $122.26 Million | $88.90 Billion | -$13.55 Billion | 0.00x | N/A |
| 2021 | $86.36 Million | $102.80 Billion | -$11.69 Billion | 0.00x | N/A |
| 2022 | $67.88 Million | $99.15 Billion | $4.76 Billion | 0.00x | 0.01x |
| 2023 | $50.72 Million | $96.72 Billion | $8.06 Billion | 0.00x | 0.01x |
| 2024 | $45.90 Million | $119.52 Billion | $5.70 Billion | 0.00x | 0.01x |
Competitor Companies of 052260 by Market Capitalization
Companies near HYUNDAI BIOLAND Co.Ltd in the global market cap rankings as of August 4, 2026.
Key companies related to HYUNDAI BIOLAND Co.Ltd by market ranking:
- NeoPharm CO. LTD (KQ:092730): Ranked #19006 globally with a market cap of $103.51 Million USD ( ₩152.74 Billion KRW).
- Globon Co. Ltd (KQ:019660): Ranked #23400 globally with a market cap of $32.70 Million USD ( ₩48.25 Billion KRW).
- Gentrogroup Co. Ltd. (KQ:083660): Ranked #29409 globally with a market cap of $3.08 Million USD ( ₩4.54 Billion KRW).
- Korea Refract (KO:010040): Ranked #23374 globally with a market cap of $32.92 Million USD ( ₩48.58 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #19006 | NeoPharm CO. LTD | KQ:092730 | $103.51 Million | ₩19120.00 |
| #23400 | Globon Co. Ltd | KQ:019660 | $32.70 Million | ₩1659.00 |
| #29409 | Gentrogroup Co. Ltd. | KQ:083660 | $3.08 Million | ₩230.00 |
| #23374 | Korea Refract | KO:010040 | $32.92 Million | ₩1371.00 |
HYUNDAI BIOLAND Co.Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, HYUNDAI BIOLAND Co.Ltd's market cap moved from $129.15 Million to $ 32.83 Million, with a yearly change of -10.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩32.83 Million | -24.80% |
| 2025 | ₩43.66 Million | -4.87% |
| 2024 | ₩45.90 Million | -9.52% |
| 2023 | ₩50.72 Million | -25.27% |
| 2022 | ₩67.88 Million | -21.40% |
| 2021 | ₩86.36 Million | -29.36% |
| 2020 | ₩122.26 Million | +16.63% |
| 2019 | ₩104.82 Million | +35.10% |
| 2018 | ₩77.59 Million | -19.55% |
| 2017 | ₩96.44 Million | +13.44% |
| 2016 | ₩85.01 Million | -34.17% |
| 2015 | ₩129.15 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of HYUNDAI BIOLAND Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.83 Million USD |
| MoneyControl | $32.83 Million USD |
| MarketWatch | $32.83 Million USD |
| marketcap.company | $32.83 Million USD |
| Reuters | $32.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About HYUNDAI BIOLAND Co.Ltd
HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more